CONFERENCE COMMITTEE REP. NO. 43

Honolulu, Hawaii

, 2019

RE: H.B. No. 665

H.D. 2

S.D. 1

C.D. 1

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

Honorable Ronald D. Kouchi

President of the Senate

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

Sirs:

Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 665, H.D. 2, S.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

The purpose of this measure is to exempt health care providers from the requirement to consult the electronic prescription accountability system when prescribing controlled substances when the patient is an inpatient, in post-operative care, or is receiving hospice or other palliative care for a terminal disease.

Your Committee on Conference has amended this measure by making technical, nonsubstantive amendments to the preamble of this measure for clarity, consistency, and style.

As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 665, H.D. 2, S.D. 1, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 665, H.D. 2, S.D. 1, C.D. 1.

Respectfully submitted on behalf of the managers:

ON THE PART OF THE SENATE

ON THE PART OF THE HOUSE

____________________________ ROSALYN H. BAKER Chair	____________________________ JOHN M. MIZUNO Co-Chair
____________________________ KARL RHOADS Co-Chair	____________________________ CHRIS LEE Co-Chair
	____________________________ ROY M. TAKUMI Co-Chair